Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.

Lesher AM, Zhou L, Kimura Y, Sato S, Gullipalli D, Herbert AP, Barlow PN, Eberhardt HU, Skerka C, Zipfel PF, Hamano T, Miwa T, Tung KS, Song WC.

J Am Soc Nephrol. 2013 Jan;24(1):53-65. doi: 10.1681/ASN.2012060570. Epub 2012 Nov 30.

PMID:
23204401
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.

Ruseva MM, Vernon KA, Lesher AM, Schwaeble WJ, Ali YM, Botto M, Cook T, Song W, Stover CM, Pickering MC.

J Am Soc Nephrol. 2013 Jan;24(1):43-52. doi: 10.1681/ASN.2012060571. Epub 2012 Nov 26.

PMID:
23184055
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Dense deposit disease and C3 glomerulopathy.

Barbour TD, Pickering MC, Terence Cook H.

Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002. Review.

PMID:
24161036
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.

Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.

PMID:
22456601
[PubMed - indexed for MEDLINE]
5.

Unexpected role for properdin in complement C3 glomerulopathies.

Daha MR.

J Am Soc Nephrol. 2013 Jan;24(1):5-7. doi: 10.1681/ASN.2012111110. Epub 2012 Dec 14. No abstract available.

PMID:
23243211
[PubMed - indexed for MEDLINE]
Free Article
6.

C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.

Ruseva MM, Takahashi M, Fujita T, Pickering MC.

Clin Exp Immunol. 2014 Apr;176(1):84-92. doi: 10.1111/cei.12244.

PMID:
24279761
[PubMed - indexed for MEDLINE]
7.

Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.

Licht C, Fremeaux-Bacchi V.

Thromb Haemost. 2009 Feb;101(2):271-8. Review.

PMID:
19190809
[PubMed - indexed for MEDLINE]
8.

Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.

Rose KL, Paixao-Cavalcante D, Fish J, Manderson AP, Malik TH, Bygrave AE, Lin T, Sacks SH, Walport MJ, Cook HT, Botto M, Pickering MC.

J Clin Invest. 2008 Feb;118(2):608-18. doi: 10.1172/JCI32525.

PMID:
18202746
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.

Martínez-Barricarte R, Heurich M, Valdes-Cañedo F, Vazquez-Martul E, Torreira E, Montes T, Tortajada A, Pinto S, Lopez-Trascasa M, Morgan BP, Llorca O, Harris CL, Rodríguez de Córdoba S.

J Clin Invest. 2010 Oct;120(10):3702-12. doi: 10.1172/JCI43343. Epub 2010 Sep 13.

PMID:
20852386
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

C3 glomerulopathy: what's in a name?

D'Agati VD, Bomback AS.

Kidney Int. 2012 Aug;82(4):379-81. doi: 10.1038/ki.2012.80.

PMID:
22846813
[PubMed - indexed for MEDLINE]
11.

Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3 glomerulopathy.

Hawfield A, Iskandar SS, Smith RJ.

Am J Kidney Dis. 2013 May;61(5):828-31. doi: 10.1053/j.ajkd.2012.11.045. Epub 2013 Feb 5. Review.

PMID:
23391537
[PubMed - indexed for MEDLINE]
12.

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M.

Nat Genet. 2002 Aug;31(4):424-8. Epub 2002 Jul 1.

PMID:
12091909
[PubMed - indexed for MEDLINE]
13.

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.

Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ.

Clin J Am Soc Nephrol. 2011 May;6(5):1009-17. doi: 10.2215/CJN.07110810. Epub 2011 Mar 17.

PMID:
21415311
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Complement and diseases: defective alternative pathway control results in kidney and eye diseases.

Zipfel PF, Heinen S, Józsi M, Skerka C.

Mol Immunol. 2006 Jan;43(1-2):97-106. Review.

PMID:
16026839
[PubMed - indexed for MEDLINE]
15.

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.

Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.

J Med Genet. 2007 Mar;44(3):193-9. Epub 2006 Oct 3.

PMID:
17018561
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.

Pickering MC, de Jorge EG, Martinez-Barricarte R, Recalde S, Garcia-Layana A, Rose KL, Moss J, Walport MJ, Cook HT, de Córdoba SR, Botto M.

J Exp Med. 2007 Jun 11;204(6):1249-56. Epub 2007 May 21.

PMID:
17517971
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Causes of alternative pathway dysregulation in dense deposit disease.

Zhang Y, Meyer NC, Wang K, Nishimura C, Frees K, Jones M, Katz LM, Sethi S, Smith RJ.

Clin J Am Soc Nephrol. 2012 Feb;7(2):265-74. doi: 10.2215/CJN.07900811. Epub 2012 Jan 5.

PMID:
22223606
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.

Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ.

Kidney Int. 2012 Aug;82(4):465-73.

PMID:
22673887
[PubMed - indexed for MEDLINE]
19.

Pathology after eculizumab in dense deposit disease and C3 GN.

Herlitz LC, Bomback AS, Markowitz GS, Stokes MB, Smith RN, Colvin RB, Appel GB, D'Agati VD.

J Am Soc Nephrol. 2012 Jul;23(7):1229-37. doi: 10.1681/ASN.2011121186. Epub 2012 Jun 7.

PMID:
22677550
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Redefining C3 glomerulopathy: 'C3 only' is a bridge too far.

Larsen CP, Walker PD.

Kidney Int. 2013 Feb;83(2):331-2. doi: 10.1038/ki.2012.385. No abstract available.

PMID:
23364589
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk